Home

Loading...

Table of contents

Transfusion strategies in critical care

What's new

Updated 2023 AABB guidelines on red blood cell transfusion strategies.

Guidelines

Key sources

The following summarized guidelines for the evaluation and management of transfusion strategies in critical care are prepared by our editorial team based on guidelines from the American Association of Blood Banks (AABB 2023), the Pan-European Multidisciplinary Task Force for Advanced Bleeding Care in Trauma (ABC-T 2023), the European Society of Intensive Care Medicine (ESICM 2021,2020), the Eastern Association for the...
Show more

Diagnostic investigations

Coagulation and viscoelastic testing: as per ABC-T 2023 guidelines, Initiate monitoring and measures to support coagulation immediately upon hospital admission of patients with traumatic hemorrhage.
B
Show 2 more
Create free account

Medical management

Tranexamic acid
As per ABC-T 2023 guidelines:
Administer tranexamic acid in patients with trauma with bleeding or at risk of significant bleeding as soon as possible, if feasible, en route to the hospital and within 3 hours after injury at a loading dose of 1 g infused over 10 minutes, followed by an IV infusion of 1 g over 8 hours.
A
Do not wait for results from a viscoelastic assessment to administer tranexamic acid.
D

Therapeutic procedures

Massive bleeding, transfusion strategies
As per ABC-T 2023 guidelines:
Insufficient evidence to recommend in favor or against using pre-hospital blood products in patients with traumatic hemorrhage.
Target hemoglobin levels of 70-90 g/L if RBC transfusion is necessary in patients with major bleeding due to trauma.
B

More topics in this section

  • Massive bleeding (platelet transfusion)

  • Massive bleeding (plasma transfusion)

  • Massive bleeding (coagulation factor transfusion)

  • Non-massive bleeding (RBC transfusion)

  • Non-massive bleeding (platelet transfusion)

  • Non-massive bleeding (plasma and fibrinogen transfusion)

  • Non-bleeding (RBC transfusion thresholds)

  • Non-bleeding (RBC transfusion prevention)

  • Non-bleeding (platelet transfusion)

  • Non-bleeding (plasma transfusion)

Specific circumstances

Pediatric patients
As per AABB 2023 guidelines:
Set a restrictive RBC transfusion threshold (< 7 g/dL) in critically ill pediatric patients and hemodynamically stable, hospitalized pediatric patients without a transfusion-dependent hemoglobinopathy, cyanotic cardiac condition, or severe hypoxemia but at risk of critical illness.
B
Consider setting transfusion thresholds in hemodynamically stable pediatric patients with congenital heart disease based on the cardiac abnormality and stage of surgical repair:
Situation
Guidance
Biventricular repair
7 g/dL
Single-ventricle palliation
9 g/dL
Uncorrected congenital heart disease
7-9 g/dL
C